Maxwell R Lloyd

13PUBLICATIONS
33CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Health and ecological risk assessmentPlanning and decision makingHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jul 09, 2026
Beyond Amplification: Precision Approaches to Targeting HER2.

|Jul 07, 2026
SERD Wars: Clinical Integration of Emerging Endocrine-Directed and Precision Therapies in Breast Cancer.

|Nov 07, 2025
Clinical and Genomic Factors Associated with Elacestrant Outcomes in ESR1-Mutant Metastatic Breast Cancer.

Maxwell R Lloyd, Caroline M Weipert, Azka Ali

|Dec 20, 2023
Artificial intelligence for triaging of breast cancer screening mammograms and workload reduction: A meta-analysis of a deep learning software.

Debora Xavier, Isabele Miyawaki, Carlos Alberto Campello Jorge

|Aug 04, 2022
Next-generation selective estrogen receptor degraders and other novel endocrine therapies for management of metastatic hormone receptor-positive breast cancer: current and emerging role.

Maxwell R Lloyd, Seth A Wander, Erika Hamilton

|Nov 02, 2021
Mechanisms of Resistance to CDK4/6 Blockade in Advanced Hormone Receptor-positive, HER2-negative Breast Cancer and Emerging Therapeutic Opportunities.

Maxwell R Lloyd, Laura M Spring, Aditya Bardia

Pageof 3

Frequent Collaborators

3 joint publications

Seth A Wander

2 joint publications

Eric P Winer

2 joint publications

Nancy U Lin

2 joint publications

Aditya Bardia